The recent conviction of Brett Blackman, founder and CEO of HealthSplash, in a sprawling $1 billion Medicare fraud scheme underscores deep structural vulnerabilities in federal healthcare programs that extend far beyond a single bad actor. According to the Department of Justice, Blackman and co-conspirators targeted hundreds of thousands of vulnerable Medicare beneficiaries—primarily seniors—using foreign call centers, spam mailers, and aggressive telemarketing to push medically unnecessary orthotic braces and other durable medical equipment (DME). Orders were routed through a software platform acquired in 2017, generating prescriptions via telemedicine physicians who often had minimal or no genuine patient interaction, sometimes falsifying in-person exams. Suppliers then paid kickbacks and billed federal programs, resulting in over $450 million in improper payouts from Medicare and programs serving veterans.[1][1]

Blackman, previously positioning himself as a healthcare technology innovator promoting blockchain-enabled platforms for 'friction-free' care, saw his company DMERx become the engine of what prosecutors called a 'billion-dollar fraud machine.' A co-defendant, Gary Cox, was previously convicted and sentenced to 15 years. Blackman faces up to 20 years when sentenced in August 2026. Evidence included undercover operations revealing sham contracts designed to evade audits. Officials, including Acting Attorney General Todd Blanche, described it as 'cold, calculated, industrial-scale theft' targeting the elderly.[2]

This case connects to broader patterns mainstream coverage often treats as isolated incidents. CMS reported Medicare Fee-for-Service improper payments of approximately $28.8 billion in FY2025, with durable medical equipment historically a high-risk area plagued by insufficient documentation, lack of medical necessity, and kickback schemes. While not all improper payments equal fraud, the scale reveals systemic weaknesses: the post-pandemic expansion of telehealth reduced barriers to remote 'consults' without robust identity or medical verification, enabling platforms to industrialize fraud at national scale. Foreign call centers, common in DME scams, exploit gaps in oversight of lead generation.[3]

Deeper analysis shows how fee-for-service incentives, combined with complex billing rules few beneficiaries understand, create fertile ground for exploitation. Blackman's flashy lifestyle—highlighted in DOJ releases with mansions and ostentatious displays—mirrors classic fraud indicators where proceeds fund lavish living while programs serving seniors face solvency pressures. The scheme also bilked VA and TRICARE programs, showing cross-agency vulnerabilities. Recent DOJ efforts, including a dedicated Fraud Division and alignment with task forces on waste, signal heightened scrutiny, yet such convictions remain rare relative to estimated losses.

This isn't merely one CEO's greed; it exposes how 'healthtech' can mask predatory schemes, how seniors are commodified as billing targets, and how federal spending—hundreds of billions annually—lacks the real-time auditing and beneficiary safeguards needed. Without addressing root incentives and verification failures in DME and telehealth, similar schemes will persist, draining resources meant for genuine care and accelerating distrust in public health programs.